These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12621737

  • 41. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX, Neu NM, Neu HC.
    Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
    [Abstract] [Full Text] [Related]

  • 42. [Comparison between the in-vitro antibacterial activity of fosfomycin as determined using the M.I.C. and using the antibiogram].
    Renzini G, Oliva B.
    G Ital Chemioter; 1977; 23(2):117-22. PubMed ID: 606610
    [No Abstract] [Full Text] [Related]

  • 43. [Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin].
    Lindenschmidt EG, Schassan HH.
    Immun Infekt; 1980; 8(4):121-6. PubMed ID: 6453080
    [Abstract] [Full Text] [Related]

  • 44. Cerebrospinal fluid impairs antimicrobial activity of fosfomycin in vitro.
    Sauermann R, Schwameis R, Fille M, Ligios ML, Zeitlinger M.
    J Antimicrob Chemother; 2009 Oct; 64(4):821-3. PubMed ID: 19622535
    [Abstract] [Full Text] [Related]

  • 45. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T, Takeda Y, Kotera K, Nishimura T, Takashima T, Hiromatsu K, Tabuki K, Fujimoto S, Kamiki T, Yoshizaki E, Yabuuchi E, Shimizu Y, Matsunaga K, Yamanaka K, Furuta I, Iimori M, Kodama J, Tanaka M, Maejima K, Nukina M, Takashima E, Takahashi M, Harikane O, Masutani T.
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [Abstract] [Full Text] [Related]

  • 46. Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials.
    Samonis G, Maraki S, Rafailidis PI, Kapaskelis A, Kastoris AC, Falagas ME.
    Future Microbiol; 2010 Jun; 5(6):961-70. PubMed ID: 20521939
    [Abstract] [Full Text] [Related]

  • 47. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kobayashi K, Satou K, Matsumiya H, Saito A, Terai T, Tanno Y, Nishioka K, Arakawa M, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Matsuda M, Tanimoto H, Nakata K, Nakamori Y, Kusano N.
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [Abstract] [Full Text] [Related]

  • 48. [Synergic action of the combination of fosfomycin and kanendomycin against gram-positive and gram-negative bacteria].
    Russo G, Toscano MA, Gismondo MR, Nicolosi V, Garaci E.
    Ann Sclavo; 1980 May; 22(1):77-82. PubMed ID: 7247487
    [Abstract] [Full Text] [Related]

  • 49. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T, David MF, Duluc F, Darmusey D, Tamalet C, Toga B.
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [Abstract] [Full Text] [Related]

  • 50. The evolution of the sensitivity to fosfomycin over the past two years.
    Gobernado M, Santos M, Diosdado N, Pérez F.
    Chemotherapy; 1977 Jun; 23 Suppl 1():99-103. PubMed ID: 832547
    [Abstract] [Full Text] [Related]

  • 51. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
    Reynaud A, Desnoes M, Derriennic M, Courtieu AL.
    Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
    [Abstract] [Full Text] [Related]

  • 52. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R, Oda S.
    Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856
    [Abstract] [Full Text] [Related]

  • 53. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
    Kouda M, Kumagai I, Kobayashi J, Sugai R, Matsuzaki H.
    Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
    [Abstract] [Full Text] [Related]

  • 54. Antimicrobial susceptibility of bacteria isolated in 1985--with special reference to prevalence of methicillin-resistant staphylococcus aureus and activities of cefazolin, cefotaxime and piperacillin.
    Lee SY, Chong Y, Suk JS, Kim EJ, Kim SI, Choi TY, Kim CW, Kim JM, Kim JS.
    J Korean Med Sci; 1987 Mar; 2(1):35-42. PubMed ID: 3269243
    [Abstract] [Full Text] [Related]

  • 55. [Antibacterial activity of various antibacterial agents against methicillin-resistant Staphylococcus aureus, and difference in antibacterial activity between aminoglycosides by coagulase type. Comparison of isolates obtained in the period from 1982 to 1986 and isolates in recent 6 months].
    Wada K, Kawasima T, Arakawa M, Ozaki K.
    Jpn J Antibiot; 1990 Feb; 43(2):219-27. PubMed ID: 2362349
    [Abstract] [Full Text] [Related]

  • 56. [In vitro antibacterial activity of fosfomycin].
    Giola L, Rizzu D, Zanetti S.
    G Batteriol Virol Immunol; 1979 Feb; 71(1-6):34-40. PubMed ID: 385409
    [Abstract] [Full Text] [Related]

  • 57. [Resistance spectrum of various bacteria against cefotiam in 3 Berlin clinics].
    Hahn H, Wagner J.
    Immun Infekt; 1983 Jun; 11(4):140-2. PubMed ID: 6099820
    [Abstract] [Full Text] [Related]

  • 58. In vitro susceptibility testing procedures for fosfomycin tromethamine.
    Barry AL, Fuchs PC.
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1235-8. PubMed ID: 1929270
    [Abstract] [Full Text] [Related]

  • 59. [Susceptibilities of clinical isolates to aminoglycoside antibiotics. Susceptibility of clinical isolates from patients with complex and refractory infections].
    Deguchi K.
    Jpn J Antibiot; 1982 Aug; 35(8):1977-86. PubMed ID: 7154245
    [Abstract] [Full Text] [Related]

  • 60. Fosfomycin susceptibility of canine methicillin-resistant Staphylococcus pseudintermedius isolates.
    DiCicco M, Weese S, Neethirajan S, Rousseau J, Singh A.
    Res Vet Sci; 2014 Apr; 96(2):251-3. PubMed ID: 24569298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.